CROSS-RESISTANCE ANALYSIS FOR CLINAFLOXACIN COMPARED WITH CIPROFLOXACIN, FLEROXACIN, OFLOXACIN, AND SPARFLOXACIN USING A PREDICTOR PANEL OF CIPROFLOXACIN-RESISTANT BACTERIA

被引:15
作者
CORMICAN, MG
JONES, RN
机构
[1] Medical Microbiology Division, Department of Pathology, University of Iowa College of Medicine, Iowa City
关键词
D O I
10.1093/jac/36.2.431
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clinafloxacin was significantly more active against fluoroquinolone-resistant organisms than ciprofloxacin, ofloxacin, sparfloxacin and fleroxacin. Clinafloxacin inhibited 65% of isolates at the recommended breakpoint(less than or equal to 1 mg/L) compared with only 30.0% for ciprofloxacin, 31.7% for ofloxacin, 32% for fleroxacin, and 37.7% for sparfloxacin at their recommended breakpoints. No strain susceptible to ciprofloxacin was resistant to the other compounds tested.
引用
收藏
页码:431 / 434
页数:4
相关论文
共 13 条
  • [11] INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF AT-4140, A NEW BROAD-SPECTRUM QUINOLONE
    NAKAMURA, S
    MINAMI, A
    NAKATA, K
    KUROBE, N
    KOUNO, K
    SAKAGUCHI, Y
    KASHIMOTO, S
    YOSHIDA, H
    KOJIMA, T
    OHUE, T
    FUJIMOTO, K
    NAKAMURA, M
    HASHIMOTO, M
    SHIMIZU, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1167 - 1173
  • [12] COMPARATIVE INVITRO ACTIVITY OF A NEW QUINOLONE, AM-1091
    NEU, HC
    NOVELLI, A
    CHIN, NX
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (07) : 1036 - 1041
  • [13] INVITRO AND INVIVO ACTIVITY OF DL-8280, A NEW OXAZINE DERIVATIVE
    SATO, K
    MATSUURA, Y
    INOUE, M
    UNE, T
    OSADA, Y
    OGAWA, H
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (04) : 548 - 553